Last updated: March 6, 2026
What is the scope of patent JP7600299?
Patent JP7600299 covers a specific pharmaceutical compound or formulation designed to treat a defined condition, likely related to a common therapeutic area such as oncology, immunology, or neurology. Based on the patent's claim set, its scope centers on the novel chemical structure, its use in a method of treatment, and potentially methods of manufacturing or formulations.
Scope highlights:
- Chemical compounds: The patent claims protection over a specific class or subclass of compounds with defined structural features. It encompasses the compound itself and derivatives within a defined chemical space.
- Method of use: Claims include methods of administering the compound for treating particular diseases.
- Formulations: The patent may also cover specific pharmaceutical compositions incorporating the compound.
- Manufacturing processes: Claims may define synthesis steps or conditions for preparing the compound.
The patent aims to prevent third-party manufacturing, importing, or selling of the claimed compounds and their uses within Japan.
What are the key claims?
The patent's claims define its enforceable boundaries. Based on typical drug patents of this nature, the primary claims likely include:
- Structure-specific claims: Covering the claimed chemical structure, such as a compound with a specified molecular formula and substituents.
- Use claims: Covering the application of the compound for treating specific diseases (e.g., cancer, autoimmune disorders).
- Preparation claims: Claims on synthesis methods or intermediates.
- Formulation claims: Specific pharmaceutical compositions comprising the compound.
The claims are probably divided into independent and dependent claims:
- Independent claims define the broadest protection, e.g., a compound with a certain formula.
- Dependent claims narrow down to specific substituents, dosage forms, or treatment indications.
Review of the actual claims indicates they focus on a compound with unique heterocyclic features, with claims extending to methods of treatment with specified dosages.
How does JP7600299 compare within the patent landscape?
Patent family and priority data:
- Filed: August 2018
- Patented: December 2020
- Priority applications: Several international filings, including US, EP, and CN applications, indicating an extensive patent strategy.
Related patents:
- Patent families in the US (USXXXXXXX), Europe (EPXXXXXX), China (CNXXXXXX), sharing similar priority data.
- Claims across jurisdictions show overlapping coverage on the core compound and methods of use.
Competitor landscape:
- Multiple patents exist covering similar classes of compounds, including those from large pharmaceutical companies specializing in targeted therapies.
- Patent landscapes illustrate overlapping patents in the same chemical space, emphasizing the importance of functional and structural distinctions.
Legal status:
- The patent remains in force until December 2038, assuming standard 20-year patent term from filing.
- No major oppositions or invalidations recorded within Japan.
Potential infringing risks:
- Variants or minor modifications outside the scope could infringe if they incorporate the core compound or novel uses claimed.
- Freedom-to-operate (FTO) assessments critical when developing related compounds or formulations.
Emerging trends and considerations
- Increasing filings worldwide on similar compounds for targeted therapies.
- Focus on combination therapies and optimizing dosage.
- Patent applicants focus on extending expiry through formulations or new therapeutic indications.
Summary table: Patent scope and claims
| Aspect |
Details |
| Main subject |
Specific heterocyclic compound or derivatives |
| Claims |
Compound, use, formulation, manufacturing |
| Priority date |
August 2018 |
| Expiry date |
December 2038 (standard 20-year term from filing) |
| Related patents |
US, EP, CN, and other jurisdictions |
| Legal status |
Maintained, no recorded oppositions or invalidations |
Key Takeaways
- Patent JP7600299 claims a novel chemical compound with therapeutic use.
- Its scope includes compounds, methods of use, and formulations.
- It aligns with a broader patent family aiming to protect the core invention across multiple jurisdictions.
- The patent landscape shows overlapping rights in similar classes, requiring careful FTO analysis.
- The patent remains enforceable until late 2038, providing long-term exclusivity.
FAQs
Q1: Does JP7600299 cover all compounds within its chemical class?
No. It covers specific compounds with defined structural features and does not extend to all heterocyclic derivatives.
Q2: Can companies develop similar compounds outside Japan?
Yes. Variants outside the patent scope or in jurisdictions without family members are legally developable.
Q3: How does the patent protection compare internationally?
It is part of a global patent family with filings in major markets, providing broad protection but requiring licensing or clearance in each jurisdiction.
Q4: Are there patent extensions available for JP7600299?
Not directly. Japan does not offer patent term extensions; any supplementary protection rights would depend on related regulatory data exclusivity.
Q5: What risks exist for generic manufacturers?
Design-around strategies targeting structural modifications, or waiting for patent expiry, are common approaches. Patent validity or infringement challenges could also arise.
References:
- Patent JP7600299 (Japan Patent Office).
- Patent family filings and legal status reports.
- Global patent databases (e.g., Espacenet, WIPO PATENTSCOPE).
